Antiretroviral therapy and the lipodystrophy syndrome
Tools
Tools
Tools
John, M., Nolan, D. and Mallal, S. (2001) Antiretroviral therapy and the lipodystrophy syndrome. Antiviral Therapy, 6 (1). pp. 9-20.
![[img]](http://researchrepository.murdoch.edu.au/style/images/fileicons/application_pdf.png)
Preview |
Link to Published Version: http://www.intmedpress.com/journals/avt/abstract.c...
*Subscription may be required
*Subscription may be required
Abstract
Lipodystrophy syndrome’ in the setting of HIV infection has come to encompass a collection of morphological and metabolic abnormalities linked with the use of antiretroviral therapy and other risk factors. We review the clinical literature on this subject as it has evolved historically, taking pertinent methodological issues into account.
| Publication Type: | Journal Article |
|---|---|
| Murdoch Affiliation: | Centre for Clinical Immunology and Biomedical Statistics |
| Publisher: | International Medical Press |
| Copyright: | 2001 International Medical Press |
| URI: | http://researchrepository.murdoch.edu.au/id/eprint/14959 |
 |
Item Control Page |
Downloads
Downloads per month over past year
